SOURCE: Home Solutions Health, Inc.

March 03, 2005 09:00 ET

Home Solutions Health Announces Retail Sales Strategy for 2005; Building Hemorrelief Product Awareness, Marketing to Medical Device Distributors

NEW YORK, NY -- (MARKET WIRE) -- March 3, 2005 -- Home Solutions Health, Inc. (OTC: HSHL) announces their retail sales strategy plan for 2005. The Company plans to build Hemorrelief product awareness through relationships with medical device distributors. Placing Hemorrelief in high-profile pharmacies and retail chains could be realized through partner distribution agreements with medical device distributors. The Company is mounting an aggressive sales campaign in 2005 targeting U.S. distributors expecting to expand sales into domestic pharmacy chains within 12-18 months.

Steven Bingaman, CEO of Home Solutions Health, states, "Hemorrelief is in its 2005 sales penetration phase; securing partner agreements with medical device distributors. We plan use these distributors to seize market share in retail over-the-counter sales to hemorrhoid sufferers, our most important embedded market segment. We are diligently pursuing agreements that would get the product into high-profile, high-footfall drug stores and nationwide retail chains. This type of shelf exposure could quickly position high-value Hemorrelief as a household name. Our aggressive distributor marketing strategy has already generated inquiries from European, Middle East and Asian distributors that could quickly place Hemorrelief in the international markets."

Hemorrelief is a treatment device that uses no chemicals or medications and requires no prescription. A patented cooling method approved by the FDA, it is inserted into/around the affected area for 10 minutes. Hemorrelief maintains a controlled cooling temperature just above 32 degrees, relieving hemorrhoid pain and improving hemorrhoid conditions. According to medical research, 89% of those suffering from a wide range of hemorrhoid conditions recovered in 10 days using Hemorrelief.

About Home Solutions Health

Home Solutions Health, the licensee of Hemorrelief, explains that 100 million Americans suffer from occasional hemorrhoid pain that can develop at any time. Hemorrhoid sufferers subsequently spend $2 billion a year on treatment with 3.5 million seeking advice from a doctor. The Company notes an increase in hemorrhoids reported after 30 years of age with 50% of those over 50 years of age claiming occasional or serious hemorrhoid problems.

This release contains forward-looking statements with respect to the results of operations and business of Home Solutions Health, Inc. (OTC: HSHL) and subsidiaries, which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. Home Solutions Health, Inc. intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information